News
Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and ...
Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people ...
10h
TipRanks on MSNBlink Charging price target lowered to $5 from $8 at H.C. WainwrightH.C. Wainwright analyst Sameer Joshi lowered the firm’s price target on Blink Charging (BLNK) to $5 from $8 and keeps a Buy rating on the shares ...
With Bitcoin (BTCUSD) prices up 22% over the past month and Coinbase (COIN) set to join the S&P 500 Index ($SPX) next week in ...
ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ
PRINCETON, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today ...
On Monday, H.C. Wainwright analyst Amit Dayal maintained a Buy rating and a $3.50 price target on TOMI Environmental Solutions (NASDAQ:TOMZ), following the company’s release of its first-quarter ...
Detailed price information for Vor Biopharma Inc (VOR-Q) from The Globe and Mail including charting and trades.
H.C. Wainwright raised the firm’s price target on Oculis (OCS) to $32 from $29 and keeps a Buy rating on the shares. The firm says the ...
WALTHAM, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that management will participate in a fireside chat at the H.C. Wainwright 3 rd Annual BioConnect Investor ...
DUBLIN, May 13, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of ...
Nanobiotix to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ Date: Tuesday, May 20, 2025 Time: 5:00 pm EDT / 11:00 pm CEST Location: New York, NY Presenters: Bart van Rhijn, Chief Financial & ...
BOSTON, May 07, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results